Seifert R, Kersting D, Rischpler C, Sandach P, et al. Interim FDG-PET analysis to identify patients with aggressive non-Hodgkin lymphoma who benefit from treatment intensification: a post-hoc analysis of the PETAL trial. Leukemia 2022 Oct 14. pii: 10.1038/s41375-022-01713.
PMID: 36241697